



Fundamentals of light-cell-polymer interactions in
photo-cross-linking based bioprinting
Citation for published version (APA):
Nieto, D., Marchal Corrales, J. A., Jorge de Mora, A., & Moroni, L. (2020). Fundamentals of light-cell-
polymer interactions in photo-cross-linking based bioprinting. APL Bioengineering, 4(4), [041502].
https://doi.org/10.1063/5.0022693





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 06 May. 2021
APL Bioeng. 4, 041502 (2020); https://doi.org/10.1063/5.0022693 4, 041502
© 2020 Author(s).
Fundamentals of light-cell–polymer
interactions in photo-cross-linking based
bioprinting  
Cite as: APL Bioeng. 4, 041502 (2020); https://doi.org/10.1063/5.0022693
Submitted: 23 July 2020 . Accepted: 21 September 2020 . Published Online: 12 October 2020
 Daniel Nieto,  Juan Antonio Marchal Corrales,  Alberto Jorge de Mora, and  Lorenzo Moroni
COLLECTIONS
Paper published as part of the special topic on Biophysics of Biofabrication
 This paper was selected as Featured
 This paper was selected as Scilight
ARTICLES YOU MAY BE INTERESTED IN
Illuminating interactions in light-based bioprinting
Scilight 2020, 421101 (2020); https://doi.org/10.1063/10.0002283
Functional hydrogel bioink, a key challenge of 3D cellular bioprinting
APL Bioengineering 4, 030401 (2020); https://doi.org/10.1063/5.0018548
Addressing present pitfalls in 3D printing for tissue engineering to enhance future potential
APL Bioengineering 4, 010901 (2020); https://doi.org/10.1063/1.5127860
Fundamentals of light-cell–polymer interactions
in photo-cross-linking based bioprinting
Cite as: APL Bioeng. 4, 041502 (2020); doi: 10.1063/5.0022693
Submitted: 23 July 2020 . Accepted: 21 September 2020 .
Published Online: 12 October 2020
Daniel Nieto,1,2,3,a) Juan Antonio Marchal Corrales,3,4,5 Alberto Jorge de Mora,6 and Lorenzo Moroni2
AFFILIATIONS
1Photonics4Life Research Group, Department of Applied Physics, Faculty of Physics, University of Santiago de Compostela,
Santiago de Compostela 15782, Spain
2Complex Tissue Regeneration Department, MERLN Institute for Technology Inspired Regenerative Medicine,
Universiteitssingel 40, 6229ER Maastricht, The Netherlands
3Department of Human Anatomy and Embryology, Institute of Biopathology and Regenerative Medicine,
University of Granada, Granada 18016, Spain
4Instituto de Investigacion Biosanitaria de Granada (ibs.GRANADA), Granada 18012, Spain
5Excellence Research Unit “Modeling Nature” (MNat), University of Granada, Granada 18016, Spain
6SERGAS (Galician Health Service) and IDIS (Health Research Institute of Santiago de Compostela (IDIS),
Orthopaedic Department, Universidad de Santiago de Compostela, Santiago de Compostela 15782, Spain
Note: This paper is part of the special issue on Biophysics of Biofabrication.
a)Author to whom correspondence should be addressed: daniel.nieto@usc.es
ABSTRACT
Biofabrication technologies that use light for polymerization of biomaterials have made significant progress in the quality, resolution, and
generation of precise complex tissue structures. In recent years, the evolution of these technologies has been growing along with the development
of new photocurable resins and photoinitiators that are biocompatible and biodegradable with bioactive properties. Such evolution has allowed the
progress of a large number of tissue engineering applications. Flexibility in the design, scale, and resolution and wide applicability of technologies
are strongly dependent on the understanding of the biophysics involved in the biofabrication process. In particular, understanding cell–light
interactions is crucial when bioprinting using cell-laden biomaterials. Here, we summarize some theoretical mechanisms, which condition cell
response during bioprinting using light based technologies. We take a brief look at the light–biomaterial interaction for a better understanding of
how linear effects (refraction, reflection, absorption, emission, and scattering) and nonlinear effects (two-photon absorption) influence the biofabri-
cated tissue structures and identify the different parameters essential for maintaining cell viability during and after bioprinting.
VC 2020 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/5.0022693
I. INTRODUCTION
Bioprinting is a fast emerging technique, which makes biofabri-
cating artificial tissues and the microscale deposition of living cells pos-
sible.1,2 The ultimate objective of bioprinting is to create 3D artificial
tissues that mimic the natural biological microenvironments, where
cells can function as well as they would in real tissues. The structural
geometry and morphology of artificial structures should be controlled
using bioprinting tools to maintain high functionality at various
dimension scales to mimic the tissue complexity.3,4
Light-based biofabrication methods have been developed and
used to generate biological scaffolds and complex tissue structures.5,6
The optical nature of light (noncontact, optically selective, and precise
processing) positions these technologies at the forefront of biofabrica-
tion techniques with the ability for high precision biofabrication at
submicrometer resolution (<1lm).
Most light based printers can be divided by the light source used
for polymerization (using one photon or two photons), which is then
projected over a bath filled with liquid photo to cross-linkable biomate-
rials or cell-laden hydrogels onto a moving stage. Most common light-
based technologies using photopolymerization include laser-based
SLA, mask-based SLA, and digital light projection (DLP) using digital
mirror devices (DMDs). These technologies are based on one photon
polymerization, initially using UV light7–10 and more recently visible
light.11–13 On the other hand, multiphoton polymerization-based 3D
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laser lithography14 is based on the absorption of two photons of near
infrared light (NIR), to excite the same energy transition as ultraviolet
(UV)one-photon absorption for cross-linking the biomaterial.
A. SLA
Conventional SLA was in fact the first technology introduced by
Charles Hull in the 1980s for creating 3D constructs using UV light to
polymerize materials.15 This was followed by other studies discussing
the kinetic modeling of linear, cross-linking photopolymerization and
highlighting the opportunities as industrially cured coatings and dental
fillings, and more generally three-dimensional rapid prototyping tech-
niques.16,17 SLA bioprinting presents some advantages in comparison
with other bioprinting techniques, such as extrusion and inkjet sys-
tems. SLA bioprints photosensitive hydrogels in a layer by layer fash-
ion rather than in struts or droplets. The bioprinting time for each
layer is the same, but the total biofabrication time of the hole structure
depends on the thickness. This bioprinting characteristic of SLA
reduces the biofabrication time of the hole tissue structure. Moreover,
SLA is a nozzle-free bioprinting technique, which avoids the inconve-
nience associated with nozzle-based bioprinting technologies, resulting
in cell-laden structures with viability higher than 90%.18,19
Commonly, SLA uses the light source that impinges into a bath filled
with a photosensitive biomaterial, which is placed onto a Z moving
stage. The Z stage moves down to a predefined distance and the mate-
rial is polymerized. This distance determines the vertical resolution of
the SLA printer. More recently, a top-down approach was used, where
the light source that was placed below the bath containing the bioma-
terial, in this case, the Z platform, is moved up to a distance which
determines the thickness of the layer and hence Z resolution. Mask-
based SLA uses a mask and a light source to project the photomask
[Fig. 1(d)]. Laser-based SLA uses laser, which is focused using a lens
with XYZ movement to transfer the pattern. Bioprinting speeds using
SLA are higher than other conventional methods. Nevertheless, this
method presented poor biocompatibility with low resolution.20
Although, initial studies have reported feature sixes of 150lm per sin-
gle layer and with axial resolution250lm,21,22 with the development
of biomaterials and hydrogels, the biocompatibility and resolution of
FIG. 1. (a) A tumor angiogenesis model: (i) schematic showing the tumor angiogenesis model; (ii) schematic of the mask for printing; (iii) bioprinted microvasculature; and (iv)
bioprinted tumor model. (b) A skeletal muscle model: (i) schematic showing the skeletal muscle tissue; (ii) schematic of the mask for printing; (iii) bioprinted skeletal tissue
model; and (iv) PrestoBlue measurements of cell proliferation in the bioprinted structures. (c) A tendon-to-bone insertion model: (i) schematic of the tendon-to-bone insertion
site; (ii) schematic of the mask for printing; (iii) bright-field optical image showing a bioprinted dye-laden GelMA structure; and (iv) bioprinted tendon-to-bone model.
Reproduced with permission from Miri et al., Adv. Mater. 30, 1800242 (2018). Copyright 2018 John Wiley and Sons. (d) Schematics of stereolithographic bioprinting process:
(i) laser-based and (ii) mask-based. (e) Schematic of the DLP bioprinting process: (i) gray scale digital mask and (ii) images of fluorescently labeled hiPSC-derived hepatic pro-
genitor cells (hiPSC-HPCs). Reproduced with permission from Ma et al., Proc. Natl. Acad. Sci. U. S. A. 113, 2206–2211 (2016). Copyright 2016 PNAS. (f) The cross section of
a TPP-bioprinted mouse paw bone imaged using scanning electron microscopy and the intricate contours within the structure that arose from the bioprinting process. (g)
Schematic illustration of the experimental setup for two-photon bioprinting along with a zoomed description of focal plane and distribution of light intensity in the laser focus of a
Gaussian beam is shown. Images (f) and (g) were reproduced with permission Miri et al., Lab Chip 19, 2019–2037 (2019).50 Copyright 2019 Royal Society of Chemistry.
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SLA improved to 50lm.18 SLAs have been commonly used in
manufacturing industries and more recently used for tissue engineer-
ing applications. Initially, SLA has been used for bone tissue models.
Catros et al. used an SLA bioprinter for patterning nanohydroxyapa-
tite (nHA) and osteoblastic cells in 2D and adapted to the biofabrica-
tion of 3D composite materials toward healing bone defects.23 Wang
used an SLA bioprinting system in combination with visible photosen-
sitive bioinks [poly(ethylene glycol) diacrylate (PEGDA), gelatin meth-
acryloyl (GelMA), and eosin Y based photoinitiator], resulting in NIH
3T3 cell bioprinting with 50lm resolution and high cell viability.24
B. Digital light projection
The printing speed of SLA can be significantly improved by
using mask-less DMD-based bioprinting. The DMD-based bio-
printing uses an array of micromirrors (the dimension of each
micromirror can be in the order of 5–10 lm) to selectively
switch the light intensity of each micromirror (each individual
mirror can be controlled on two positions, being either 0-dark
or 1-light reflecting and with speeds on the order of kilohertz)
and project it over light-sensitive biopolymers that polymerize
the preselected light patterns transferred by the DMD in a layer
by layer fashion [Fig. 1(e)]. DMD technology has arisen as an
alternative for high-throughput DLP printing, resulting in good
biocompatibility for seeding cells.25 Zhu et al. used a DMD bio-
printer for generating prevascularized tissue models with com-
plex geometries (widths 50 lm and heights ffi50 lm) using a
bioink of endothelial cells, GelMA, and glycidal methacrylate–-
hyaluronic acid.26 Miri et al. were able to generate biological tis-
sue structures such as tumor angiogenesis [Fig. 1(a)], muscle
strips [Fig. 1(b)], and musculoskeletal junctions [Fig. 1(c)] with
printing resolutions on the order of 10 lm by using a DMD
bioprinter working at 365 nm, in combination with microflui-
dics.8 Ma et al. have used DMD to fabricate hexagonal lobule
structures of GelMA (15% w/v) seeded with HUVECs (Human
Umbilical Vein Endothelial Cells) (with a resolution 50 lm)
that where incorporated on a liver-on-a-chip.27 These studies
highlight the high speed of bioprinting associated with DMD
(under 1 min), accuracy (10–50 lm), and versatility (from bio-
compatible scaffolds to cell-laden structures with different
geometries) of the mask-less methods.
C. Multiphoton polymerization-based 3D laser
lithography
The challenge associated with 3D biofabrication using single-
photon photopolymerization is to avoid the off-focal photopo-
lymerization that may ultimately cure undesirable parts of the
designed construct.28,29 Biofabrication using multiphoton
polymerization benefits from the high resolution inherent in
the two-photon polymerization (TPP) process, which can gen-
erate 3D structures with micro/nanoscale resolution [Fig.
1(f)].30 The nonlinear optical phenomenon associated with
TPP occurs when irradiating using a focused femtosecond
laser beam at infrared wavelength, by simultaneous absorption
of multiple photons, which induces photopolymerization of a
small area (100 nm), based on the radical generation due to
the interaction between the used photoinitiator and the femto-
second laser beam. This interaction allows the generation of
3D tissue structures with ultra-high-resolution (from lm to
nm) that cannot be achieved by other conventional photolitho-
graphic methods.31 Ovsianikov et al. used TPP to fabricate bio-
degradable tissue scaffolds using gelatin modified with metha-
crylamide (GelMod), which were seeding with adipose-derived
stem cells, presenting good adhesion and resulting in prolifera-
tion and differentiation to adipocytes.32 Koroleva et al. demon-
strated that hybrid Zr–Si porous scaffolds were fabricated
using TPP promoted mesenchymal stem cells (hMSCs) to dif-
ferentiate toward the osteogenic lineage.33 Commonly used
TPP systems include two X–Y galvanometric scanners to move
the laser focus in the X–Y coordinates and a high resolution Z
stage that performs axial scanning [Fig. 1(g)]. Due to the
coherent properties of the laser beam with optimal focusing
capabilities, the TPP process can generate high-resolution 3D
features. Nevertheless, the throughput is restricted by the
sequential laser scanning process. This limitation is further
enhanced when printing complex hollow structures or large
volume structures. Different optical solutions have been pro-
posed, which include microlens arrays, spatial light modula-
tors, and diffractive optical elements, most of them based on
splitting the laser into multiple foci. Geng et al. have used TPP
in combination with a DMD scanner for generating tens of
laser foci that can be controlled individually by achieving
diffraction-limited resolution (500 nm–1600 nm) and a proc-
essing speed of 22.7 kHz.34 These studies highlighted the
opportunities of TPP associated with high resolution features.
Nevertheless, several key challenges still remain, which include
the failure of biofabricating cell-laden constructs with clinically
relevant dimensions. TPP systems that are commercially avail-
able are very expensive and are difficult to adapt to the particu-
lar application. The dearth of biomaterials (biocompatible and
biodegradables) for TPP is another inconvenience for covering
different biological applications. The dearth of water soluble
PIs limits the uses of photopolymers with high water contents.
Although TPP is very precise, it is a relatively slow process,
which results in small scaffolds of structures difficult to handle
in tissue engineering. Biological experiments need statistical
experiments with a huge amount of identical structures. In this
sense, efforts need to be taken to develop novel photopolymers
and photoinitiators for TPP aimed at increasing the fabrication
speed and reducing cytotoxic effects.
Table I shows the characteristics of the most common light based
technologies using photopolymerization.
D. Basic light interaction process during bioprinting
During photolithographic biofabrication, the primary light inter-
actions can be caused mainly by linear phenomena of refraction,
reflection, absorption, emission, and scattering and nonlinear effects
as in the case of multiphoton polymerization.35 Reflection occurs
when light reflects on the surface of the biomaterial without penetrat-
ing it. Refraction occurs as a consequence of the change in the propa-
gation angle of light when it passes from air to the biomaterial during
bioprinting. Absorption and dispersion that occur both in a biological
APL Bioengineering REVIEW scitation.org/journal/apb
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biomaterial and in cells are dependent on the wavelength of light,
which is complete through intracellular and extracellular constituents.
Emission is a phenomenon that consists of an energy transmission to
the atoms of the biological component, in which their electrons are
promoted to higher levels of energy. While the energy of photons used
to irradiate cells has a dramatic impact on phototoxicity, it can be
expected that the bioprinting limitations are mostly related to the pho-
ton energy and the wavelength of the light source used to photo-cross-
link the biomaterials. Although cells exhibit a very distinct irradiation
sensitivity, the phototoxicity increases dramatically with decreasing
irradiation wavelength.36 Infrared light, as long as we do not pass the
cellular thermal threshold through which apoptosis and destruction
are induced, is safe. Nevertheless, ultraviolet light is mostly used for
light-curing photopolymerization on stereolithographic bioprinting
and has been reported to damage the DNA of cells.37,38
Following light absorption, in certain circumstances, cells can
undergo a wide variety of photochemical and photophysical processes,
which include fluorescence, thermal effects, photoablation effects,
plasma-induced ablation, and photodisruption.39 These effects must
be avoided during bioprinting. Photoablation occurs due to the action
TABLE I. Most common light based bioprinting technologies using photopolymerization.
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of an intense ultraviolet (UV) laser pulse that photochemically decom-
poses various cellular and extracellular components. Plasma-induced
ablation and photodisruption occur as a consequence of exposing the
biological material to a power density above 1011W/cm2.40
Fluorescence originates from the transition from an excited singlet
state to a ground state vibrational mode. Thermal effects are the result
of the conversion of absorbed light energy into heat. The above-
mentioned mechanisms need to be considered carefully to increase
cell viability. Light power, selected wavelengths, and exposure time are
perhaps the main determinants that dominate the process during light
based biofabrication. It is essential to adapt the light beam and opti-
mize the light parameter to minimize cell damage without losing its
ability to light cure or achieve cross-linking in the medium. Most
Stereolithography (SLA) printers can be divided by the light source
used for polymerization (using one photon or two photons), which is
then projected over a bath filled with liquid photo to cross-linkable
biomaterials or cell-laden hydrogels onto a moving stage. Although
photo-cross-linking is typically associated with SLA bioprinting,
other biofabrication technologies, such as extrusion, may use photo-
cross-linking as a secondary process. Bram et al. have used extrusion
bioprinting based on a two-step cross-linking approach. Secondary
photo-cross-linking was applied for shape maintenance. This two-step
cross-linking methodology can be used with a broad window of extrusion
biofabrication parameters that allow printing at a low viscosity (4mPas)
to maintain high cell viability (>80%) and with good shape fidelity. This
eliminates the problems associated with low viscosity bioinks (complex
chemical modifications, multiple initiation systems, and viscosity
enhancers).59 There is a vast amount of reviews covering the advantage
and disadvantages of different bioprinting technologies and more recently
the fundamentals and practical aspects of light based bioprinting,41,42 but
few of them covering the primary cell–light interactions.
In this article, we consider the impact and behavior of light dur-
ing bioprinting, focusing on high resolution structures with high cell
viability. Section II is related to polymer–light interactions centered on
high resolution structures. Section III is devoted to biophysical princi-
ples at that cell–light interaction level and parameters involved to
maintain high cell viability, and Sec. IV presents a future outlook and
conclusions.
II. POLYMER–LIGHT INTERACTIONS
Photopolymerization comprises the reaction of monomers that
form large networks when irradiated with light (by the single-photon
or two-photon absorption). This absorption can be promoted by the
reactant monomer or by the transfer of energy absorbed by a photoini-
tiator.43 Photoinitiators used for photopolymerization generate free
radicals when they are exposed to light and react with monomers and/
or oligomers for initiating polymer chain reactions and growth.
A. Photopolymerization mechanism (single-photon vs
two-photon)
During photopolymerization, the photon interactions at the ini-
tial step differ from the ordinary thermal polymerization, but the fol-
lowing steps being propagation, termination, and chain transfer
remain the same. Under such premises, the photopolymerization bio-
printing process can be classified into two categories: single-photon
photopolymerization and multiphoton photopolymerization (Fig. 2).
In single-photon SLA, the polymerization process is originated
via linear single-photon absorption [Fig. 3(a)].44 The energy of the
FIG. 2. Diagram of stereolithographic processes based on the exciton radiation form and energy (single photon and multi-photon).
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photon, Ep, is equivalent or superior than the material bandgap Eg.
With Ep ¼ hv ¼ hc=k being the governing law of this process, it
means that high energy photons and short wavelengths are required.
In most cases, UV wavelengths shorter than 365nm are selected. One
photon absorption with Ep>Eg motivates the electron to move from
the valence band to the conduction band. This process alters the
chemical bond inducing polymerization process, which is responsible
for biomaterial cross-linking. Noncoherent light sources at low power
levels can also induce linear absorption. Nevertheless, as the light
intensity increases, typically using coherence laser sources, nonlinear
absorption can take place. The UV (kUV) photosensible biomaterial
can be also photopolymerized by infrared (IR) wavelengths of nearly
double wavelength (kIR¼ 2kUV).45 TPP is based on this mechanism
and comprises the absorption of two photons simultaneously through
a virtual state for molecule excitation [Fig. 3(a)]. The virtual levels
(fs) have a particularly short lifetime, which results in the instanta-
neous absorption of almost two photons. This excitation process
depends quadratically on the incident light intensity46 and the TPP
requires high light intensities (>GW/cm2). The TPP process can be
described as follows:47 a molecule in a ground energy state Gs is
excited to an excited state Es. In this process, the molecules absorb two
single photons (Gs and Es are separated with an energy difference of
Ef above the Gs) as shown in Fig. 3(a). A virtual state Vs is created by
the absorption of the two photons [both photons having the same
energy levels¼E1 (degenerate, Ef¼ 2E1)]. With further excitation,
they lose energy and move to another state R, where vibrational relaxa-
tion is induced by the lowest vibrational level of the lowest-energy Es
[Fig. 3(a), dashed arrow], and then return to the ground state by a
pathway that can be radiative or nonradiative.
The TPP process is originated precisely at the focal volume of the
laser beam [Fig. 3(b)], which facilitates the generation of precise and
high-resolution 3D structures. The biggest limiting factor in the exten-
sive use of TPP for biological applications is the slow manufacturing
time that accompanies high-resolution structuring which can compro-
mise cell viability. This can be overcome by using optical systems to
modulate the behavior of light. Gittard et al. have demonstrated TPP
using a multiple spotlight approach by generating microstructure
arrays for tissue engineering. Computer-generated hologram patterns
were used to generate multiple spotlights from one laser beam, signifi-
cantly reducing the manufacturing time. These multiple foci were used
to simultaneously produce multiple tissue scaffolds by TPP.48 Atry
et al. demonstrated the applicability of diffractive optical elements for
fabricating large scaffolds at rates several times faster than by single
spotlight.49
The two key properties that conditioned the resolution of
laser direct write bioprinting, mask based SLA, and DMD-based
bioprinting processes, which are mainly determined by the thick-
ness of the photosensitive resin, are the directionality of the
FIG. 3. (a) Single-photon and two-photon absorption processes, (b) Gaussian beam profile of a laser beam, and (c) single-photon and two photon absorption features on the
biomaterial.
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impinging light and the lower scattering of light (perpendicular to
the laser). The thickness (z resolution) can be controlled by adjust-
ing the laser characteristics (pulse width, light wavelength, power,
repetition rate, and size of the beam) and the properties of the resin
(including viscosity and superficial stress).50 According to the
polymerization kinetics of the photo-cross-linking mechanisms,







where Cd is the depth of curing (lm), Dp is the depth of penetration
(lm), Ei is the irradiation of light (mJ/cm
2), and Ec is the threshold
value of energy of the gelation point for the liquid resin (mJ/cm2). As
Ei approaches Ec, the layer is cured, and the resin is solidified. Because
of the nonlinear nature of two photon polymerization and the thresh-
old behavior, high-quality and high-resolution features can be
obtained. By adjusting different laser parameters (pulse energy and
pulse repetition rate), the printing resolution (<100nm) can be
increased by overcoming the diffraction limit.
The two-photon absorption mechanism happens in a resin
that initially does not absorb the selected wavelength of the laser
light, allowing its penetration in the material [Fig. 3(c)]. The bio-
printing resolution of TPP is related to the incident laser light and
the square of its intensity. A high magnification focal lens focuses
laser energy at a small focal point where the highest amount of
absorption takes place. Assuming a Gaussian laser beam profile
with an intensity distribution I(r, z) at distances (z in the direction
of propagation and r along the cross section) from the center can
be defined as






w zð Þ2 ;
where I0, x0, and x(z) are the intensity at the center of the Gaussian
beam (r¼ 0, z¼ 0), the waist of the beam, and the radius of the beam
in the plane with a distance of z, respectively. The average intensity at





where W is the power average, 1 is the width of the selected pulse, f is
the repetition rate, h is the Planck constant, and t is the frequency of
light. The photon-polymerization is initiated when the density of radi-
cals P (r, z) surpasses the threshold Pth [P (r, z)  Pth]. The intensity
at the focal plane (z¼ 0) reaches the threshold, where





All the aforementioned interactions and effects have influence
over the bioprinting process.
B. Photoinitiators
The polymerization efficiency of the developed bioinks depends
strongly on the selection of the photoinitiator. The photoinitiator
should be efficient in free radical generation with low toxicity. For
engineering of living tissues, photoinitiators sensitive to UV are the
most used. Photoinitiators can be separated into two categories (in
relationship with the radical generation mechanisms): (1) Type-I
photoinitiators (cleavable photoinitiators) and (2) Type-II (bimolecu-
lar photoinitiating). During bioprinting, for initiating polymerization,
Type-I photoinitiators generate two radicals. The starting process of
Type-II (e.g., benzophenone/tertiary amine) presents more complex-
ity. For example, benzophenone is excited and promotes fast electron
transfer (from the lone pair of tertiary amine), which is followed by
the proton transfer process; this process provides the radical (H-
donor) that initiates photopolymerization. To avoid the UV light dam-
aging effects, including DNA damage and cancer effects,51 some visible
light photoinitiators have been investigated and demonstrated to be
useful for bioprinting with cells. LAP (lithium phenyl-2,4,6-trimethyl-
benzoylphosphinate) is a UV photosensible photoinitiator, which has
also been demonstrated to be sensitive to blue light (near UV).52 Eosin
Y (20,40,50,70-tetrabromofluorescein disodium salt) is sensitive around
514 nm. Hydrogels developed for working with Eosin Y maintain cell
function and present less toxicity than Irgacure 2959 (1-[4-(2-hydrox-
yethoxy)-phenyl]-2-hydroxy-2-methyl-1-propanone).53–55 Natural
photoinitiators such as Riboflavin (FR) and Vitamin B2, were demon-
strated to induce photo-cross-linking on alginate hydrogels56 and were
used as visible light photoinitiators in the thiol–ene polymerization of
polyethylene glycol (PEG)-based hydrogels.57 A photoinitiator based
on a ruthenium complex [tris-bipyridyl-ruthenium (II) hexahydrate]
and sodium persulfate (SPS) was used to initiate visible light cross-
linking of hyaluronic acid/gelatin-based bioinks.58 Soliman et al. have
used ruthenium (Ru) and sodium persulfate (SPS) cross-linkers in
combination with allyl-functionalized gelatin (Gel-AGE) bioink for
extrusion bioprinting based on the dual-step cross-linking approach,
where a primary (partial) cross-linking in the absence of light is per-
formed to alter the bioink’s rheological properties with subsequent sec-
ondary post-printing cross-linking for shape maintenance.59 Lim et al.
have used a Vis þ Ru/SPS system, demonstrating better cell cytocom-
patibility than the commonly used UV þ I2959 system. Encapsulated
cells remained >85% viable even when using high Ru/SPS concentra-
tions, visible-light intensities, and longtime exposure times (21 days),
which highlight the potential Vis þ Ru/SPS system to avoid the cell
damage associated with UV light and for maintaining high cell viabil-
ity, shape fidelity, and metabolic activity.60 More recently, poly-a-
ketoester based photoinitiators have demonstrated good cell viability
in combination with methacrylates and polyethylene glycol (PEG)
diacrylate-based hydrogels.61 It appears, therefore, clear that visible
light sensible materials are emerging as optimal PI for cell-laden bio-
inks for bioprinting. A list of the commonly used PIs and their light
absorbing peaks are showed in Table II.
III. CELL–LIGHT INTERACTIONS
Human cells vary in size in a range from 5 lm of erythrocytes
(red blood cells), 20 lm of leukocytes, to tens of centimeters of neuro-
nal axons.62 They can therefore be either larger or smaller than the
light wavelength used for bioprinting. The interaction of cells and cell-
laden biomaterials with light can be caused mainly by linear phenom-
ena of refraction, reflection, absorption, emission, and scattering.63
During bioprinting, the light refracts when it travels from the
light source (by air at a particular angle) and reaches a substance (bio-
material) which presents another refractive index. The refractive index
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determines the phase and speed of light propagation. Reflection occurs
when light reflects on the surface of the biomaterial without penetrat-
ing in it, due to the difference between the refractive index of air and
biomaterial. Reflection at the microscopic level will depend on the cell
surface morphology and because of it will not be uniform. Light
absorption is complete through intracellular and extracellular constitu-
ents and occurs as a consequence of the transition from a grown state
(low energy state) to an excited state (high energy state) of a
molecule.64,65
Emission is a phenomenon that consists of energy transmission
to the atoms of the biological component, in which their electrons are
promoted to higher levels of energy, in some circumstances unstable,
leaving holes under them. When electrons return to these holes with
less energy, the excess of energy is returned as light, with different
characteristics from the incident ray. Scattering occurs due to loss of
directionality of light and spread of the light beam spot. This phenom-
enon is what regulates the light intensity distribution in the cell-laden
biomaterials.
Light scattering in tissues is dominated by Mie scattering. This
type of scattering occurs when particles are the same size as the wave-
length of light (when particles are much smaller than the wavelength,
Rayleigh scattering predominates). Cells, nuclei, and organelles all fall
into this classification. In addition, the lipid membranes that enclose
these structures have a different refractive index than the surrounding
medium (around 1.5). The dispersion of light into the tissue is moti-
vated by the differences of the refractive index. When the difference
between the medium and the cells increases, the dispersion also
increases. The relationship with the wavelength can be complex, but in
general, the longer the wavelength, the lower the scattering, which
indeed is one of the benefits of TPP.66
In Rayleigh scattering, subcellular components such as organelles
can be a scattering component. This type of scattering depends mostly
on the following parameters: the dimensions of the scattering com-
pounds (cells or organelles in bioprinting), scattering centers and the
surrounding medium refractive index variations, and the light wave-
length [see Fig. 4(b)].67 We can consider that Rayleigh scattering is
inversely proportional to the square of the wavelength of light. That
means that a short wavelength (UV) will be more scattered than a
long wavelength (IR). By taking scattering individually as a mechanism
for optical loss during bioprinting, we can assume that the longer the
wavelength is, the deeper will the light penetrate into a cell laden bio-
material sample [Fig. 4(a)].
Absorption is controlled by Beer’s law, especially when working
with monochromatic beams.68 It establishes empirically an absorption
coefficient in the matter, and corelates this absorption to the wave-
length of the incident light. In studies mainly on human skin tissues,
due to a high interest in being an area permanently exposed to radia-
tion, an increase in absorption and less penetration of light with
shorter wavelengths (in studies with wavelengths from 300 to 800 nm)
has been demonstrated.69 This law is valid in liquid media such as cel-
lular and intracellular interstitial fluids, and establishes an increase in
absorption with the concentration of solute in the medium in cell-
laden biomaterials. Let us consider a sample which is in a solution,
contained in a box which is transparent to the radiation of interest
(monochromatic) and with uniform thickness. With I0 being the
intensity of the radiation that enters the sample and I being the inten-
sity of the radiation that goes across the sample, the transmittance T is






where b is the thickness of the box, c is the concentration of the sample
in the solution, and a is the capacity of the sample to absorb radiation.
Beer’s law can be simplified as A¼ abc, with A being the absorbance,






Beer’s law says that the concentration and the absorbance are linearly pro-
portional (when the cell thickness and the radiation wavelength remain
constant). Therefore, both the absorption and the dispersion that occur
both in a biological biomaterial and in cells are conditioned by the wave-
length and increased in the blue region of the electromagnetic spectrum
compared to the red and infrared regions.69 Following light absorption,
cells undergo a wide variety of photochemical and photophysical pro-
cesses. Some cellular elements generate fluorescence (emissivity) as they
are excited directly or when they get energy from another cellular element.
This is defined as autofluorescence and the constituent it emits is called
fluorochrome. Fluorescence, which has a half-life between 1 and 10 ns,
originates from the energy transition (excited singlet state to a ground
state vibrational mode).70 Other processes that can be observed in light–
biological matter interactions, apart from the autofluorescence discussed
above and photochemical processes, are thermal effects, photoablation
effects, photodisruption, and plasma-induced ablation.40
Thermal effects can be considered as the result of the conversion
of absorbed light energy into heat. They can be produced by pulsed
and continuous wave (CW) lamps and lasers. They are nonspecific,
TABLE II. Common PIs used in light-based bioprinting.
Name (chemical) Abbreviation Absorbing peak (nm) Sources
20,40,50,70-Tetrabromofluorescein disodium salt Eosin Y 514 54, 55
2,20-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] VA-086 385 53
Lithium phenyl-2,4,6-trimethylbenzoylphosphinate LAP 375 52
1-[4–(2-Hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propanone Irgacure 2959 257 8
Riboflavin (Vitamin B2) RF 220–240 56, 57
Ruthenium with a reagent (sodium persulfate) Ru (SPS) 400–450 58–60
Poly-a-ketoester based photoinitiators Poly-a-ketoesters 330 61
APL Bioengineering REVIEW scitation.org/journal/apb
APL Bioeng. 4, 041502 (2020); doi: 10.1063/5.0022693 4, 041502-8
VC Author(s) 2020
which means that these effects are not wavelength dependent. Two
critical limitations to consider are the maximum level of temperature
that the cells can reach and the propagation of heat in the cells.
Photoablation is a process that occurs due to the effect of a high
intense ultraviolet (UV) light (typically a short laser pulse) that photo-
chemically decomposes cells and extracellular constituents. The pro-
duced ablation is tightly localized at the point of the light beam,
outside of which it does not occur. The power densities are on the
order of 107–1010W/cm2. Plasma-induced ablation and photodisrup-
tion occur as a consequence of exposing the biological material to an
irradiance above 1011W/cm2, producing an electric field that causes
dielectric breakdown of matter and generates a high electronic density
(plasma). The generated plasma absorbs strongly in the UV, visible,
and infrared regions causing ablation. With high plasma energies, the
structure of the biological material is broken by mechanical impact.
Photodisruption is not localized and can spread in biological materials
or cells adjacent to the rupture zone.
Infrared light, as long as we do not pass the cellular thermal
threshold through which apoptosis and destruction are induced, is
safe. Nevertheless, the UV light is mostly used for light-curing photo-
polymerization on stereolithographic bioprinting. This radiation is the
one that is being used with more intensity in new technological bio-
printing developments. There are several manufacturers that use wave-
lengths of approximately 405nm in 3D photopolymerization
bioprinting for the generation of solid structures from cell-laden
biomaterials. At the biological level, excessive exposure can induce
changes in DNA and is associated with mutagenesis and the appear-
ance of tumors. Cells have mechanisms to fight against light-induced
damage (both thermal and mutagenic). Among these mechanisms, we
can highlight the activation of molecules of the heat shock protein
(HSP) group,71 proteins of the p53 group, and anti-inflammatory cas-
cades mediated by IL-17F among others.51 Alterations in these signal-
ing pathways or molecules can trigger individual cellular susceptibility
to UV radiation [Fig. 3(c)]. This damage can also be cumulative, espe-
cially in predisposing cells. Toxicity of UV radiation varied with wave-
lengths and exposure doses. Masuma et al. have investigated the
toxicological effects of a range of UV wavelengths (250nm–310 nm).72
The energy doses leading to cell death increased by increasing the
wavelength. The lethal dose for killing cells at 250 nm was 120 mJ/
cm2, while the doses required to damage cells working at 310nm was
6 J/cm2.
During stereolithographic biofabrication, all the above-
mentioned mechanisms need to be considered to increase cell viability.
Light power, selected wavelengths, and exposure time are perhaps the
main determinants during the biofabrication process (Fig. 5). Catros
et al. have investigated the effect of laser energy on the viability of
endothelial cells. They found that with a 1064nm laser and energy
configuration around 8 lJ, with a frequency of 5 KHz, cell damage
was not induced, which if ascends to 24 lJ an increase in cell mortality
can be expected.73 It is essential to adapt the light beam and optimize
FIG. 4. (a) Wavelength dependence of light penetration in cell-laden biomaterials, (b) sketch of light–cell interaction mechanism, and (c) diagram of the cell-laden biomaterial
absorption mechanism.
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it to minimize cell damage without losing its ability to light cure or
achieve cross-linking in the medium. The risk associated with the
damage of cells during the TPP process needs to be considered pru-
dently for efficient cell-laden biomaterial development. It was demon-
strated that when using femtosecond laser pulses (790 nm, 1.5W, 140
fs), the cytoskeleton of cells can be damaged. The energy of the pulse
necessary for biomaterial photopolymerization and its modification by
TPP is lower than the energy required for damaging the cytoskeleton
structure due to laser ablation. Since TPP is a low thermal process,
cells, proteins, and other agents can be added to the bioink without
considering an important thermal damage associated with the bio-
printing process, which in addition to preserving the DNA from being
damaged is a critical point for its application in tissue engineering.
One of the main parameters affecting cell viability when using
photosensible polymers is the use of UV light. During the photo-
cross-linking progression, the PI absorbs the UV light and generates
free radicals, which form the polymer network by polymerization.74
So, the light seems to be a critical parameter here; photons must have
enough energy to induce the photopolymerization reaction, but
remain below an energy damage threshold to avoid DNA damage or
reactive oxygen species (ROS). For preserving cell viability, the quan-
tum field (photons emitted in response to the light absorbing mole-
cule) is important to consider, and the PI needs to preserve low
irradiation energy for photopolymerization.75,76 Most PIs suitable for
bioprinting, including Eosin Y and benzylidene cyclanone dyes,
own high quantum yields for a low energy wavelength (800nm).
FIG. 5. Diagram of the incident light parameters in relationship with cell viability.
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Salt-based PIs (LAP and Irgacure 2959) own high quantum yields
with conversion kinetics very fast for a high energy wavelength
(400nm).77 Thus, cytocompatibility wavelength ranges usually are
in the range of near-UV light (k¼ 300–400nm). In fact, using several
photoinitiators has been proved to maintain high cell viability working
at low concentrations with short UV exposure time and low intensity
resulting in good cell viability. Miri et al. have used LAP in combina-
tion with poly(ethylene glycol) diacrylate (PEGDA) and gelatin metha-
cryloyl (GelMA) at LAP concentrations of (1.0% w/v) and (0.03% w/v),
respectively. Using a DMD bioprinter working at 365nm, in combina-
tion with microfluidics, they were able to generate biological tissues
structures such as tumor angiogenesis, muscle strips, and musculoskel-
etal junctions.8 However, large UV exposure times are usually required
during 3D bioprinting of thick structures, which can diminish the cell
viability or promote DNA damage of cells.78 Then, using the highest
cytocompatible light intensity and optimizing the concentration of PIs
for an efficient and fast cross-linking process in combination with a
short light exposure time allow reducing prolonged cell exposure to
free radicals.79
Recently, Ruskowitz and DeForest have demonstrated that the
rate of proliferation remains the same and no cell death was observed
when irradiating fibroblasts and human mesenchymal stem cells
(NIH3T3) with a variety of light intensities (1, 5, 10, and 20 mW
cm2) at 365 nm. Nevertheless, they found that cells increase apoptosis
by caspase activation in response to UV induced oxidative stress
resulting from a UV light exposure (k¼ 254nm, 30 s at 300lW
cm2). A deeper analysis revealed that using a UV light of 365 nm
does not alter the proteome nor shift protein production. Meanwhile,
as an effect of induced DNA damage, 24 h after the light exposure at
254 nmwavelength, 40 proteins were differentially expressed including
the down-regulation of several histones and the up-regulation of the
cellular tumor protein p53. These results showed that light-induced
cell death is wavelength-dependent, which emphasize that for 3D bio-
fabrication, using photoresponsive biomaterials is a key factor to
appropriately select light treatments.80
Bioprinting using living cells was demonstrated with primary
cells, adult stem cells, and immortalized cell lines, with a variety of bio-
printing technologies and biomaterials;81 and more recently with
induced Pluripotent stem cells (iPSCs).82 Among these cell sources,
iPSCs represent a huge potential in bioprinting for regenerative medi-
cine, modeling diseases, and toxicological studies. Since the recent dis-
covery of iPSCs and due to their unlimited self-renewal and
pluripotent differentiation capabilities, they have been used for investi-
gating disparate biological mechanisms.83 The indefinite division and
pluripotency properties of iPSCs result in an unlimited source of any
adult healthy and diseased cell type. However, iPSCs are more sensitive
to handling procedures, which can influence pluripotency and differ-
entiation. In this sense, although iPSCs are UV sensitive, the nature of
the light based bioprinting process (noncontact process) represents the
main advantage. Koch et al. have investigated laser bioprinting of
undifferentiated human iPSCs in combination with different biomate-
rials and they have analyzed their impact on pluripotency and differ-
entiation of cells. They found that hiPSCs are indeed more sensitive to
the applied biomaterials, but not to laser printing itself.84 Additionally,
iPSCs are also an attractive cell source that can avoid the ethical issues
of embryonic cells.85,86 Embryonic stem cells (ESCs) are also of great
interest for light-based bioprinting, nevertheless they are more
sensitive to DNA damage in comparison with iPSCs. For example,
mouse ESCs (mESCs) seemed to be more sensitive to UV or c-ray irra-
diation than differentiated mouse embryonic fibroblasts (MEFs).87
Regarding DNA damage response (DDR), both human iPSCs and
hESCs are analogous, showing high sensitivity to DNA damaging
agents in comparison with somatic cells.88 For bioprinting, overcom-
ing the DNA damage and cell viability related to the high UV sensitiv-
ity of iPSCs and ESCs requires novel biomaterials and photoinitiations
in the visible range. This, would make it possible to investigate in the
laboratory what is wrong in the diseased cells of an individual so that
they give rise to the manifestation of the disease. These potentials place
iPSCs in a privileged place to become, in the not too distant future, as
an essential tool in 3D bioprinting.
IV. FUTURE OUTLOOK AND CONCLUSIONS
Light–cell interactions are crucial parameters to consider in
light-based bioprinting. Light properties determine the interaction
mechanism for linear and nonlinear absorption. The light working
parameters (power, exposure time, and repetition rate) have to be con-
sidered to improve cell viability and avoid DNA damage and ROS
formation. Biomaterial thickness (representative in 3D bioprinting by
the individual layer) increases cell survival: substrates with layer
heights of 100lm showed higher cell viability compared to those of
20lm under equivalent light conditions. Biomaterial molecular weight
optimization can promote cell viability. Small molecular weights may
allow cell survival during the production process, but increase early
death in the first few days. High molecular weights on the other hand
may limit cell growth over time. Lasers and light sources with wave-
lengths in the visible spectrum range, appear to affect cell viability to a
lesser extent (avoid damage induced by spectra such as UV), and
should be of choice if technical manufacturing capabilities allow their
use. Optimizing the porosity of the material to the targeted cell line
would favor cell viability when exposed to the same light source.
Temperature in the light or printing chamber should be controlled.
Temperatures close to 30 during the manufacturing process will cer-
tainly improve cell viability. When we comment on absorption, we
highlight how the concentration of the solute increased absorption in
aqueous media. This must be key when choosing our bioinks, since
they will not only affect the primary cell viability but will also be
responsible for a greater or lesser absorption of light and consequently
the possibility of cellular damage.
The suitable photopolymers for bioprinting are expected to have
a high degree of conversion for minimizing the amount of residual
monomer and pose fast photopolymerization kinetics to reduce the
time of light exposure. An efficient photoinitiator should also have a
broad range of photoactivity speed and power to reduce cell–light
interaction time. UV light with wavelengths below 365nm will cure
the surface extremely quickly, but will damage cells. Using a wave-
length of 385nm or higher cures the material more uniformly with
low cell damage and allows the light to penetrate and cure in thicker
sections. The closer the wavelength to the visible range, the easier it is
to bioprint using cells. Most of the PIs used in tissue engineering work
within the UV wavelength range, which is indeed the major limitation
because it has been demonstrated to be harmful to the cells and to the
DMD array itself.89 Novel PIs working in the visible range are being
developed and used for visible light photopolymerization of biocom-
patible polymers and are emerging as an optimal material for tissue
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bioprinting. Some researchers have adopted visible light stereolitho-
graphic approaches using such visible PIs. Tuan et al. have used a ster-
eolithography system working in the visible range for polymerizing
polyethylene glycol diacrylate (PEGDA) hydrogel containing cells with
LAP.13 The LAP is still a UV-sensitive photoinitiator, though it can be
cross-linked by a near-UV blue light. In the visible and near visible
range, VA-086 (2,20-azobis[2-methyl-n-(2-hydroxyethyl)propiona-
mide]) which is sensitive at 385 nm (Ref. 52) and Eosin Y (20,40,50,70-
tetrabromofluorescein disodium salt), which is sensitive at 514 nm can
be included.53
Numerous innovations relating the use of TPP for biological
applications, which envisage their unique opportunities for tissue engi-
neering, have been described recently. TPP uses biomaterials and tech-
nologies that were initially developed for 3D printing. Therefore, in
order to promote its bioprinting capabilities, an interdisciplinary
approach is required to apply TPP technology for tissue engineering
and biological applications. Ovsianikov et al. reported TPP hydrogel
constructs containing cells32 where highly efficient two-photon photoi-
nitiators and GelMA (gelatine-methacrylate) were used. MG63 cells
(osteosarcoma cell lines) were encapsulated in Gel-MA; after laser
exposure, cell damage was found in the laser-irradiated spot with a
minor percentage of cells undamaged in the surroundings of the laser
irradiated area. Experiments of Control (without photoinitiators)
revealed that using the same laser parameters than those for TPP did
not damage the cells. Conversely, cell damage seemed to be related to
the cytotoxicity effects of some species, i.e., initiating radicals and ROS.
These TPP features anticipate this technology as a suitable tool for bio-
fabricating cell-laden 3D biomaterial constructs due to: (1) use of laser
radiation near to IR (800nm), which is able to penetrate deep into the
hydrogels containing cells and avoid any cell damage; (2) TPP can be
used under cell friendly conditions (pH and temperature); and (3) high
water content hydrogels can be handled by 2PP. Urcciuolo et al. have
recently demonstrated intravital 3D printing using cell-laden photosen-
sitive photopolymer hydrogels within tissues of live mice at a wave-
length of 850nm.90 Intravital 3D bioprinting could serve as an in vivo
alternative to conventional bioprinting which opens an interesting
opportunity for three-photon polymerization (3PP) using longer wave-
lengths with the associated higher penetration depth.91
The aforementioned biophysical mechanism related to the light
based bioprinting process can strongly influence the functionality, cell
survival, DNA damage, long term cell viability, and phenotype mainte-
nance of the bioprinted cell-laden structures. TPP is a promising 3D
bioprinting process that uses harmless IR light on cells. So, cell laden
bioinks are printed directly. Since tissue development involves specific
chemical, physical, and geometrical environments to accomplish their
anticipated functions, it would be required to design light sensible bio-
materials with fitting biological properties, which will influence cell–
light interactions. Although light based bioprinting can overcome the
unresolved issues related to other bioprinting tools, such as shear stress
and pressure, it must deal with the UV light toxicity for cells, which
requires the development of novel bioinks and photoinitiators to move
the working window more and more toward the visible light range.
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